FOVEA PHARMACEUTICALS has a total of 123 patent applications. Its first patent ever was published in 2007. It filed its patents most often in EPO (European Patent Office), Canada and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and medical technology are WELLSTAT THERAPEUTICS CORP, XENOPORT INC and MILNE JILL C.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 12 | |
#2 | Canada | 9 | |
#3 | WIPO (World Intellectual Property Organization) | 9 | |
#4 | China | 6 | |
#5 | South Africa | 6 | |
#6 | Australia | 5 | |
#7 | Brazil | 5 | |
#8 | Mexico | 5 | |
#9 | New Zealand | 5 | |
#10 | Peru | 5 | |
#11 | Colombia | 4 | |
#12 | Costa Rica | 4 | |
#13 | Dominican Republic | 4 | |
#14 | Ecuador | 4 | |
#15 | Republic of Korea | 4 | |
#16 | Nicaragua | 4 | |
#17 | Tunisia | 4 | |
#18 | Taiwan | 4 | |
#19 | Argentina | 3 | |
#20 | Chile | 3 | |
#21 | EAPO (Eurasian Patent Organization) | 3 | |
#22 | Israel | 3 | |
#23 | Morocco | 3 | |
#24 | Uruguay | 3 | |
#25 | Hong Kong | 2 | |
#26 | Singapore | 2 | |
#27 | Honduras | 1 | |
#28 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Medical technology | |
#4 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Acyclic or carbocyclic compounds | |
#5 | Implantable devices | |
#6 | Syringes | |
#7 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Leriche Caroline | 69 |
#2 | Middlemiss David | 54 |
#3 | Auclair Eric | 29 |
#4 | Le Roux Jacques | 22 |
#5 | Feutrill John | 20 |
#6 | Latour Elisabeth | 17 |
#7 | Middlemiss David N | 15 |
#8 | Belichard Pierre | 14 |
#9 | Pruneau Didier | 11 |
#10 | Roy Pierre | 10 |
Publication | Filing date | Title |
---|---|---|
TN2014000104A1 | Aniline derivatives,their preparation and their therapeutic application | |
TW201317205A | Aniline derivatives, their preparation and their therapeutic application | |
EP2623490A1 | 2-(3-aminophenoxy)-acetic acid derivatives as EP2 receptor agonists for use in treatment of glaucoma | |
MX2013006527A | Arylsulfonamide derivatives for the prevention or treatment of specific ophthalmologic disorders. | |
CN103402508A | Dosages of arylsulfonamide derivatives | |
TW201304773A | Arylsulfonamide derivatives for the prevention or treatment of specific ophthalmologic disorders | |
EP2570402A1 | Bi-aryl derivatives, their preparation and their therapeutic application | |
TW201204723A | Heterocyclic compounds, their preparation and their therapeutic application | |
EP2446866A1 | Apparatus for injection into an eye | |
EP2381943A1 | Substituted quinazoline compounds | |
AU2008309923A1 | Aqueous ophthalmic formulations | |
WO2008084064A1 | Apparatus for intra-ocular injection |